Literature DB >> 7198634

High performance liquid chromatography (HPLC) of natural products. IV. The use of HPLC in biosynthetic studies of cephalosporin C in the cell-free system.

R D Miller, L L Huckstep, J P McDermott, S W Queener, S Kukolja, D O Spry, T K Elzey, S M Lawrence, N Neuss.   

Abstract

A new cepham metabolite has been isolated from the filtered broth of Cephalosporium acremonium by high performance liquid chromatography (HPLC) and identified as 7 beta-(5-D-amino-adipamido)-3 beta-hydroxy-3 alpha-methyl-cepham-4 alpha-carboxylic acid (I). Pure penicillin N was prepared using HPLC in the analytical mode. When I was added in place of penicillin N as substrate for the cell-free biosynthetic of cephalosporin, no formation of deacetoxycephalosporin C (II) was observed. A synthetic cepham derivative, 7 beta-(5-D-aminoadipamido)-3-exomethylene-cepham-4 alpha-carboxylic acid (III) was also tested in the cell-free system as a possible intermediate. The compound III was shown to be an inhibitor of the ring expansion enzyme that converts penicillin N to deacetoxycephalosporin C.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198634     DOI: 10.7164/antibiotics.34.984

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Analysis of penicillin N ring expansion activity from Streptomyces clavuligerus by ion-pair high-pressure liquid chromatography.

Authors:  S E Jensen; D W Westlake; S Wolfe
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

2.  Copurification and characterization of deacetoxycephalosporin C synthetase/hydroxylase from Cephalosporium acremonium.

Authors:  J E Dotzlaf; W K Yeh
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

3.  Stereochemistry of the incorporation of valine methyl groups into methylene groups in cephalosporin C.

Authors:  C P Pang; R L White; E P Abraham; D H Crout; M Lutstorf; P J Morgan; A E Derome
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.